Belite Bio, Inc. (BLTE)
175.50
-7.66
(-4.18%)
USD |
NASDAQ |
Sep 10, 13:49
Belite Bio EPS Diluted (Quarterly) : -0.7071 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7071 |
| March 31, 2026 | -0.6757 |
| December 31, 2025 | -0.6992 |
| September 30, 2025 | -0.6529 |
| June 30, 2025 | -0.5008 |
| March 31, 2025 | -0.445 |
| December 31, 2024 | -0.3211 |
| Date | Value |
|---|---|
| September 30, 2024 | -0.2828 |
| June 30, 2024 | -0.3131 |
| March 31, 2024 | -0.2652 |
| December 31, 2023 | -0.2469 |
| September 30, 2023 | -0.4023 |
| June 30, 2023 | -0.2642 |
| March 31, 2023 | -0.3283 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.1781 |
| CorMedix, Inc. | 0.281 |
| Eloxx Pharmaceuticals, Inc. | -0.6631 |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | -0.1113 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.41M |
| Total Expenses (Quarterly) | 28.41M |
| Enterprise Value | 7.096B |
| Earnings Yield | -1.56% |
| Normalized Earnings Yield | -1.558 |